Considerations in the Use of Stimulants in Sport

Overview

Journal Sports Med

Specialty Orthopedics

Date 2015 Dec 30

PMID 26712509

Citations 7

Authors

Claudia L Reardon

Robert M Factor

Affiliations

Soon will be listed here.

Abstract

Medication treatment of adult athletes with attention-deficit/hyperactivity disorder (ADHD) is controversial. Some articles and guidelines support the use of stimulant medications in this population, while others advise against it. We believe that the important issues regarding the use of stimulant medications in athletes include the likelihood of performance enhancement, poor inter-rater reliability of ADHD diagnosis in relation to therapeutic use, policies of sport-governing bodies, psychiatric treatment of mental illness, and dangerous consequences of use. We review the literature on these five issues and conclude by discussing the ethical principle of fairness, and suggest some proposals regarding the use of stimulants by athletes that balance these five issues and fairness. Our ultimate recommendation is that stimulants should not be used by high-level adult athletes.

Citing Articles

Meldonium Supplementation in Professional Athletes: Career Destroyer or Lifesaver?.

Puscas A, But M, Vari C, osz B, Stefanescu R, Filip C Cureus. 2024; 16(7):e63634.

PMID: 39092347 PMC: 11292090. DOI: 10.7759/cureus.63634.

Exploring the scope and applications of anti-doping measures in ultramarathon: an analysis of the positions of ultramarathon race organizers.

Colangelo J, Smith A, Hachen S, Liebrenz M Front Sports Act Living. 2024; 6:1406638.

PMID: 38840955 PMC: 11150625. DOI: 10.3389/fspor.2024.1406638.

Neurodiversity in elite sport: a systematic scoping review.

Hoare E, Reyes J, Olive L, Willmott C, Steer E, Berk M BMJ Open Sport Exerc Med. 2023; 9(2):e001575.

PMID: 37342788 PMC: 10277550. DOI: 10.1136/bmjsem-2023-001575.

The therapeutic potential of exercise and caffeine on attention-deficit/hyperactivity disorder in athletes.

Sogard A, Mickleborough T Front Neurosci. 2022; 16:978336.

PMID: 36033633 PMC: 9412016. DOI: 10.3389/fnins.2022.978336.

ADHD symptoms and use of anabolic androgenic steroids among male weightlifters.

Kildal E, Hassel B, Bjornebekk A Sci Rep. 2022; 12(1):9479.

PMID: 35676515 PMC: 9178025. DOI: 10.1038/s41598-022-12977-w.

References

Reardon C, Factor R . Sport psychiatry: a systematic review of diagnosis and medical treatment of mental illness in athletes. Sports Med. 2010; 40(11):961-80. DOI: 10.2165/11536580-000000000-00000. View

Conant-Norville D, Tofler I . Attention deficit/hyperactivity disorder and psychopharmacologic treatments in the athlete. Clin Sports Med. 2005; 24(4):829-43, viii. DOI: 10.1016/j.csm.2005.05.007. View

Gapin J, Labban J, Etnier J . The effects of physical activity on attention deficit hyperactivity disorder symptoms: the evidence. Prev Med. 2011; 52 Suppl 1:S70-4. DOI: 10.1016/j.ypmed.2011.01.022. View

Vetter V, Elia J, Erickson C, Berger S, Blum N, Uzark K . Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in.... Circulation. 2008; 117(18):2407-23. DOI: 10.1161/CIRCULATIONAHA.107.189473. View

Santosh P, Sattar S, Canagaratnam M . Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults. CNS Drugs. 2011; 25(9):737-63. DOI: 10.2165/11593070-000000000-00000. View

Wilens T, Adler L, Adams J, Sgambati S, Rotrosen J, Sawtelle R . Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry. 2008; 47(1):21-31. DOI: 10.1097/chi.0b013e31815a56f1. View

Choi J, Han D, Kang K, Jung H, Renshaw P . Aerobic exercise and attention deficit hyperactivity disorder: brain research. Med Sci Sports Exerc. 2014; 47(1):33-9. PMC: 5504911. DOI: 10.1249/MSS.0000000000000373. View

Parr J . Attention-deficit hyperactivity disorder and the athlete: new advances and understanding. Clin Sports Med. 2011; 30(3):591-610. DOI: 10.1016/j.csm.2011.03.007. View

Roelands B, Hasegawa H, Watson P, Piacentini M, Buyse L, de Schutter G . Performance and thermoregulatory effects of chronic bupropion administration in the heat. Eur J Appl Physiol. 2008; 105(3):493-8. DOI: 10.1007/s00421-008-0929-x. View

10.

Kutcher J . Treatment of attention-deficit hyperactivity disorder in athletes. Curr Sports Med Rep. 2011; 10(1):32-6. DOI: 10.1249/JSR.0b013e3182091d79. View

11.

Pelham W, Burrows-MacLean L, Gnagy E, Fabiano G, Coles E, Tresco K . Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD. Exp Clin Psychopharmacol. 2005; 13(2):111-26. DOI: 10.1037/1064-1297.13.2.111. View

12.

Kang K, Choi J, Kang S, Han D . Sports therapy for attention, cognitions and sociality. Int J Sports Med. 2011; 32(12):953-9. DOI: 10.1055/s-0031-1283175. View

13.

Kamp C, Sperlich B, Holmberg H . Exercise reduces the symptoms of attention-deficit/hyperactivity disorder and improves social behaviour, motor skills, strength and neuropsychological parameters. Acta Paediatr. 2014; 103(7):709-14. DOI: 10.1111/apa.12628. View

14.

Piacentini M, Meeusen R, Buyse L, de Schutter G, Kempenaers F, Van Nijvel J . No effect of a noradrenergic reuptake inhibitor on performance in trained cyclists. Med Sci Sports Exerc. 2002; 34(7):1189-93. DOI: 10.1097/00005768-200207000-00021. View

15.

Deligiannis A, Bjornstad H, Carre F, Heidbuchel H, Kouidi E, Panhuyzen-Goedkoop N . ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes. Eur J Cardiovasc Prev Rehabil. 2006; 13(5):687-94. DOI: 10.1097/01.hjr.0000224482.95597.7a. View

16.

Sutherland S, Adler L, Chen C, Smith M, Feltner D . An 8-week, randomized controlled trial of atomoxetine, atomoxetine plus buspirone, or placebo in adults with ADHD. J Clin Psychiatry. 2012; 73(4):445-50. DOI: 10.4088/JCP.10m06788. View

17.

Pliszka S . Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007; 46(7):894-921. DOI: 10.1097/chi.0b013e318054e724. View

18.

Smith G, BEECHER H . Amphetamine sulfate and athletic performance. I. Objective effects. J Am Med Assoc. 1959; 170(5):542-57. DOI: 10.1001/jama.1959.63010050001008. View

19.

Humphreys K, Eng T, Lee S . Stimulant medication and substance use outcomes: a meta-analysis. JAMA Psychiatry. 2013; 70(7):740-9. PMC: 6688478. DOI: 10.1001/jamapsychiatry.2013.1273. View

20.

Putukian M, Kreher J, Coppel D, Glazer J, McKeag D, White R . Attention deficit hyperactivity disorder and the athlete: an American Medical Society for Sports Medicine position statement. Clin J Sport Med. 2011; 21(5):392-401. DOI: 10.1097/JSM.0b013e3182262eb1. View